Total Payments
$14,208
2024 Payments
$2,899
Companies
40
Transactions
164
Medicare Patients
847
Medicare Billing
$99,360
Payment Breakdown by Category
Consulting$6,435 (45.3%)
Food & Beverage$4,883 (34.4%)
Other$1,700 (12.0%)
Travel$840.60 (5.9%)
Education$349.92 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,435 | 4 | 45.3% |
| Food and Beverage | $4,883 | 142 | 34.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,700 | 1 | 12.0% |
| Travel and Lodging | $840.60 | 3 | 5.9% |
| Education | $349.92 | 14 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $5,017 | 9 | $0 (2024) |
| Exelixis Inc. | $2,256 | 8 | $0 (2022) |
| TAIHO ONCOLOGY, INC. | $2,117 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $468.79 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $425.96 | 13 | $0 (2024) |
| Janssen Biotech, Inc. | $308.19 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $281.41 | 11 | $0 (2023) |
| Amgen Inc. | $274.51 | 9 | $0 (2022) |
| Genentech USA, Inc. | $259.63 | 12 | $0 (2022) |
| PFIZER INC. | $241.37 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,899 | 15 | TAIHO ONCOLOGY, INC. ($2,100) |
| 2023 | $673.24 | 16 | Galvanize Therapeutics, Inc ($156.27) |
| 2022 | $348.70 | 10 | Genentech USA, Inc. ($92.02) |
| 2021 | $521.55 | 12 | Lilly USA, LLC ($139.34) |
| 2020 | $13.93 | 1 | Kite Pharma, Inc. ($13.93) |
| 2019 | $4,648 | 8 | Incyte Corporation ($4,559) |
| 2018 | $3,836 | 44 | Exelixis Inc. ($2,217) |
| 2017 | $1,268 | 58 | Merck Sharp & Dohme Corporation ($203.32) |
All Payment Transactions
164 individual payment records from CMS Open Payments — Page 6 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 09/07/2017 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Oncology | ||||||
| 09/06/2017 | INSYS Therapeutics Inc | SYNDROS (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Chemotherapy-Induced Nausea and Vomiting | ||||||
| 08/24/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Oncology | ||||||
| 08/03/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Education | In-kind items and services | $5.11 | General |
| Category: ONCOLOGY | ||||||
| 07/13/2017 | Novartis Pharmaceuticals Corporation | RYDAPT (Drug), TASIGNA | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: HEMATOLOGY | ||||||
| 07/12/2017 | Taiho Oncology, Inc. | Lonsurf (Drug) | Food and Beverage | Cash or cash equivalent | $16.94 | General |
| Category: Oncology | ||||||
| 07/06/2017 | Genentech USA, Inc. | Zelboraf (Biological), Erivedge, COTELLIC | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: BioOncology | ||||||
| 07/06/2017 | Genentech USA, Inc. | Zelboraf (Biological), Erivedge, COTELLIC | Food and Beverage | In-kind items and services | $1.28 | General |
| Category: BioOncology | ||||||
| 06/29/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: ONCOLOGY | ||||||
| 06/15/2017 | TESARO, Inc. | VARUBI (Drug), ZEJULA | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: ONCOLOGY | ||||||
| 06/14/2017 | PFIZER INC. | SUTENT (Drug), XALKORI, INLYTA | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 06/07/2017 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), AFINITOR, VOTRIENT | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: ONCOLOGY | ||||||
| 05/18/2017 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: BioOncology | ||||||
| 05/11/2017 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Oncology | ||||||
| 05/10/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $61.44 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/04/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Oncology | ||||||
| 04/27/2017 | Amgen Inc. | Neulasta (Biological), Vectibix | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Oncology | ||||||
| 04/25/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Education | In-kind items and services | $5.11 | General |
| Category: ONCOLOGY | ||||||
| 04/21/2017 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $65.00 | General |
| Category: BioOncology | ||||||
| 04/19/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $33.49 | General |
| Category: Oncology | ||||||
| 04/19/2017 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: ONCOLOGY | ||||||
| 04/19/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: ONCOLOGY | ||||||
| 04/13/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: Oncology | ||||||
| 04/12/2017 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 151 | 206 | $32,688 | $14,914 |
| 2022 | 3 | 220 | 411 | $63,638 | $31,130 |
| 2021 | 3 | 234 | 446 | $64,134 | $32,382 |
| 2020 | 3 | 242 | 378 | $50,343 | $20,934 |
Total Patients
847
Total Services
1,441
Medicare Billing
$99,360
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 88 | 119 | $17,530 | $7,718 | 44.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 36 | 57 | $12,268 | $5,950 | 48.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 27 | 30 | $2,890 | $1,246 | 43.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 130 | 234 | $33,092 | $15,480 | 46.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 49 | 131 | $26,032 | $13,512 | 51.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 41 | 46 | $4,514 | $2,138 | 47.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 149 | 306 | $41,954 | $21,041 | 50.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 45 | 90 | $17,840 | $9,253 | 51.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 40 | 50 | $4,340 | $2,088 | 48.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 153 | 258 | $33,752 | $14,041 | 41.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 39 | 63 | $10,980 | $5,281 | 48.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 50 | 57 | $5,611 | $1,612 | 28.7% |
About Dr. Anisa Hassan, M.D
Dr. Anisa Hassan, M.D is a Hematology & Oncology healthcare provider based in Joplin, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164537643.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anisa Hassan, M.D has received a total of $14,208 in payments from pharmaceutical and medical device companies, with $2,899 received in 2024. These payments were reported across 164 transactions from 40 companies. The most common payment nature is "Consulting Fee" ($6,435).
As a Medicare-enrolled provider, Hassan has provided services to 847 Medicare beneficiaries, totaling 1,441 services with total Medicare billing of $99,360. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Joplin, MO
- Active Since 08/21/2006
- Last Updated 04/12/2011
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1164537643
Products in Payments
- Cabometyx (Drug) $2,256
- LONSURF (Drug) $2,100
- OPDIVO (Biological) $280.90
- KISQALI (Drug) $211.87
- KEYTRUDA (Biological) $191.91
- ERLEADA (Drug) $180.24
- LIBTAYO (Biological) $160.09
- ALIYA SYSTEM (Device) $156.27
- Imbruvica (Drug) $142.63
- JAKAFI (Drug) $123.19
- Orserdu (Drug) $123.11
- REBLOZYL (Biological) $120.43
- Trodelvy (Drug) $120.31
- IMBRUVICA (Drug) $118.61
- VYXEOS (Drug) $117.34
- PYLARIFY (Drug) $112.86
- AFINITOR (Drug) $112.13
- TECENTRIQ (Biological) $109.65
- GILOTRIF (Drug) $105.00
- XTANDI (Drug) $100.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Joplin
Matthew Miller, D.o, D.O
Hematology & Oncology — Payments: $7,036
Hematology & Oncology $7,036
Regine Leconte, M.d, M.D
Hematology & Oncology — Payments: $6,937
Hematology & Oncology $6,937
Dr. Kerry Williams-Wuch, M.d, M.D
Hematology & Oncology — Payments: $3,800
Hematology & Oncology $3,800
Samir Dalia, Md, MD
Hematology & Oncology — Payments: $3,276
Hematology & Oncology $3,276
Amir Anis
Hematology & Oncology — Payments: $3,158
Hematology & Oncology $3,158
Dr. Pamela Landon, M.d, M.D
Hematology & Oncology — Payments: $2,717
Hematology & Oncology $2,717